Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

Background: Antimalarial drugs were widely used as experimental therapies against COVID-19 in the initial stages of the pandemic. Despite multiple randomized controlled trials demonstrating unfavorable outcomes in both efficacy and adverse effects, antimalarial drugs are still prescribed in developi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano-Cruz, Oscar Arturo, Jiménez, José Víctor, Olivas-Martinez, Antonio, Ortiz-Brizuela, Edgar, Cárdenas-Fragoso, José Luis, Azamar-Llamas, Daniel, Rodríguez-Rodríguez, Sergio, Oseguera-Moguel, Jorge Carlos, Dorantes-García, Joel, Barrón-Magdaleno, Clemente, Cázares-Diazleal, Aldo C, Román-Montes, Carla Marina, Tamez-Torres, Karla María, Martínez-Guerra, Bernardo Alfonso, Gulias-Herrero, Alfonso, González-Lara, María Fernanda, Ponce-de-León-Garduño, Alfredo, Kershenobich-Stalnikowitz, David, Sifuentes-Osornio, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210417/
https://www.ncbi.nlm.nih.gov/pubmed/34149420
http://dx.doi.org/10.3389/fphar.2021.668678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210417/
https://www.ncbi.nlm.nih.gov/pubmed/34149420
http://dx.doi.org/10.3389/fphar.2021.668678

Ejemplares similares